Vorapaxar-d5 Sulfate
PLD1 抑制剂；(1R,2R)-N-((S)-1-(4-(5-溴-2-酮基-2,3-二氢-1H-苯并[d]咪唑-1-基)哌啶-1-基)丙-2-基)-2-苯基环丙烷甲酰胺
Vorapaxar-d5 Sulfate
PLD1 抑制剂；(1R,2R)-N-((S)-1-(4-(5-溴-2-酮基-2,3-二氢-1H-苯并[d]咪唑-1-基)哌啶-1-基)丙-2-基)-2-苯基环丙烷甲酰胺
Vorapaxar-d5 Sulfate
-
产品编号： CVR758202
-
分子式：C25H29BrN4O2
-
分子量：497.43
英文别名：
(1R,2R)-N-((S)-1-(4-(5-Bromo-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-phenylcyclopropanecarboxamide
参考文献：
Boyle, J., et al.: Curr. Vasc. Pharmacol., 3, 63 (2005), Jennings, L., et al.: Expert. Opin. Drug Metab. Toxicol., 1, 727 (2005), Chackalamannil, S., et al.: J. Med. Chem., 49, 5389 (2006),
Labelled Vorapaxar (V758200). SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis.
搜索质检报告(COA)
搜索MSDS
